Literature DB >> 18451564

Two new triterpenes from the Rhizome of Dryopteris crassirhizoma, and inhibitory activities of its constituents on human immunodeficiency virus-1 protease.

Ji Suk Lee1, Hirotsugu Miyashiro, Norio Nakamura, Masao Hattori.   

Abstract

Two new hopane type triterpenes, named dryopteric acids A (1) and B (2), were isolated from the Rhizome of Dryopteris crassirhizoma (Aspiadaceae) together with sixteen known compounds (3-18). Of isolated compounds, ursolic acid (15), and dryopteric acid A (1) and B (2) showed potent inhibitory activities against HIV-1 protease with IC50 values of 8.9-44.5 microM. In addition, acetylated compounds 1 and 2 appreciably increased inhibitory activities with their IC50 values of 1.7 and 10.8 microM, respectively.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18451564     DOI: 10.1248/cpb.56.711

Source DB:  PubMed          Journal:  Chem Pharm Bull (Tokyo)        ISSN: 0009-2363            Impact factor:   1.645


  13 in total

Review 1.  Recent Progress in the Development of HIV-1 Protease Inhibitors for the Treatment of HIV/AIDS.

Authors:  Arun K Ghosh; Heather L Osswald; Gary Prato
Journal:  J Med Chem       Date:  2016-01-22       Impact factor: 7.446

2.  In vivo anthelmintic effect of flavonol rhamnosides from Dryopteris crassirhizoma against Dactylogyrus intermedius in goldfish (Carassius auratus).

Authors:  Bing Jiang; Cheng Chi; Yao-wu Fu; Qi-zhong Zhang; Gao-xue Wang
Journal:  Parasitol Res       Date:  2013-09-08       Impact factor: 2.289

3.  In vivo anthelmintic activity of Dryopteris crassirhizoma, Kochia scoparia, and Polygala tenuifolia against Dactylogyrus intermedius (Monogenea) in goldfish (Carassius auratus).

Authors:  Cheng Lu; Hong-Yu Zhang; Jie Ji; Gao-Xue Wang
Journal:  Parasitol Res       Date:  2011-08-14       Impact factor: 2.289

Review 4.  Plant-derived triterpenoids and analogues as antitumor and anti-HIV agents.

Authors:  Reen-Yen Kuo; Keduo Qian; Susan L Morris-Natschke; Kuo-Hsiung Lee
Journal:  Nat Prod Rep       Date:  2009-08-13       Impact factor: 13.423

5.  Anti-Influenza Virus (H5N1) Activity Screening on the Phloroglucinols from Rhizomes of Dryopteris crassirhizoma.

Authors:  Juan Wang; Yan-Tao Yan; Shen-Zhen Fu; Bing Peng; Lin-Lin Bao; Yan-Ling Zhang; Jing-Hong Hu; Zu-Ping Zeng; Dong-Hao Geng; Zeng-Ping Gao
Journal:  Molecules       Date:  2017-03-08       Impact factor: 4.411

6.  Interaction of Flavonoids from Woodwardia unigemmata with Bovine Serum Albumin (BSA): Application of Spectroscopic Techniques and Molecular Modeling Methods.

Authors:  Rui Ma; Hong Pan; Tao Shen; Peng Li; Yanan Chen; Zhenyu Li; Xiaxia Di; Shuqi Wang
Journal:  Molecules       Date:  2017-08-09       Impact factor: 4.411

7.  Antiplatelet Activity of Acylphloroglucinol Derivatives Isolated from Dryopteris crassirhizoma.

Authors:  Nam-Hui Yim; Jung-Jin Lee; BoHyoung Lee; Wei Li; Jin Yeul Ma
Journal:  Molecules       Date:  2019-06-13       Impact factor: 4.411

8.  Water Extract of Dryopteris crassirhizoma Attenuates Bone Loss by Suppressing Osteoclast Differentiation and Function.

Authors:  Hyunil Ha; Ki-Shuk Shim; Taesoo Kim; Hyosun An; Jin Yeul Ma
Journal:  Evid Based Complement Alternat Med       Date:  2013-05-20       Impact factor: 2.629

Review 9.  Medicinal Plants Used in the Treatment of Human Immunodeficiency Virus.

Authors:  Bahare Salehi; Nanjangud V Anil Kumar; Bilge Şener; Mehdi Sharifi-Rad; Mehtap Kılıç; Gail B Mahady; Sanja Vlaisavljevic; Marcello Iriti; Farzad Kobarfard; William N Setzer; Seyed Abdulmajid Ayatollahi; Athar Ata; Javad Sharifi-Rad
Journal:  Int J Mol Sci       Date:  2018-05-14       Impact factor: 5.923

10.  In vivo and in vitro anti‑allergic and anti‑inflammatory effects of Dryopteris crassirhizoma through the modulation of the NF‑ĸB signaling pathway in an ovalbumin‑induced allergic asthma mouse model.

Authors:  Chun Hua Piao; Thi Tho Bui; Yan Jing Fan; Thi Van Nguyen; Dong-Uk Shin; Chang Ho Song; So-Young Lee; Hee Soon Shin; Hyoung Tae Kim; Ok Hee Chai
Journal:  Mol Med Rep       Date:  2020-08-25       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.